Organon & Co
791 hedge funds and large institutions have $4.57B invested in Organon & Co in 2022 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 247 increasing their positions, 299 reducing their positions, and 125 closing their positions.
34% more call options, than puts
Call options by funds: $17.5M | Put options by funds: $13.1M
0.03% more ownership
Funds ownership: 76.56% → 76.59% (+0.03%)
7% less funds holding
Funds holding: 853 → 791 (-62)
17% less repeat investments, than reductions
Existing positions increased: 247 | Existing positions reduced: 299
30% less capital invested
Capital invested by funds: $6.55B → $4.57B (-$1.99B)
38% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 125
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$51.1M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$32.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$30.1M |
| 4 |
Bank of New York Mellon
New York
|
+$25.2M |
| 5 |
Millennium Management
New York
|
+$21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Smead Capital Management
Phoenix,
Arizona
|
-$43.7M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$42.6M |
| 3 |
Fayez Sarofim & Co
Houston,
Texas
|
-$33.7M |
| 4 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
-$31.3M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$30.8M |
OGN Hedge Fund Activity: Q3 2022 in Review
791 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q3 2022, worth a combined $4.57B — down 30% from $6.55B a quarter earlier.
Sellers outnumbered buyers: 125 funds closed out of OGN and 77 opened new positions — a net loss of 48 holders — while 299 trimmed existing stakes and 247 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $51.1M. The largest seller was Smead Capital Management, exiting entirely with an estimated $43.7M sold.
- 791 institutional investors held Organon & Co (OGN) as of Q3 2022, down from 853 in Q2 2022.
- Funds reported $4.57B of Organon & Co stock for Q3 2022, down 30% quarter-over-quarter.
- 77 funds opened new Organon & Co positions in Q3 2022 and 125 closed out, a net change of -48 holders.
- The largest Organon & Co buyer in Q3 2022 was Armistice Capital, an estimated $51.1M added.
- The largest Organon & Co seller in Q3 2022 was Smead Capital Management, an estimated $43.7M sold.
Based on aggregated 13F filings for Q3 2022.